Siplizumab Not Yet Recruiting Phase 2 Trials for Kidney Transplantation Prevention

Indications	Status	Purpose	Phase
DBCOND0028022 (Kidney Transplantation)	Not Yet Recruiting	Prevention	2

clinicaltrials.gov Identifier	Title	Drugs
NCT05669001	A Study of TCD601 in de Novo Renal Transplant Recipients	Belatacept (DB06681) Mycophenolic acid (DB01024) Siplizumab (DB06371) Tacrolimus (DB00864)